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Older Black/African American adults have been underrepresented in clinical trials compared to their Caucasian peers.1–4 Enrollment disparity has been so widely recognized
that the US National Institutes of Health (NIH) released broader guidelines in 1994 to
address the historical problem of under enrollment of racial and ethnic minorities and
women.5 Disparate rates of participation are problematic, as clinical trial findings become
difficult to generalize; indeed, medications, devices, interventions, and treatments may
not be indicated for specific demographic groups based upon findings derived from
populations lacking diversity.1 Recent reviews of participant recruitment and enrollment in cancer, heart failure, surgical oncology, and lung injury trials reflect racial- and
gender-based enrollment disparities that have resulted in reduced generalizability.6–9
The factors contributing to clinical trial motivation among diverse populations
include perceived participation advantages ranging from special access to health
care and premarket treatments to a broader sense of purpose (altruism).10,11 Yet, most
of the prior research on clinical trial participation among African Americans has
21
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Purpose: Older African Americans experience disproportionately higher incidence of morbidity
and mortality related to chronic and infectious diseases, yet are significantly underrepresented
in clinical research compared to other racial and ethnic groups. This study aimed to understand
the extent to which social support, transportation access, and physical impediments function as
barriers or facilitators to clinical trial recruitment of older African Americans.
Methods: Participants (N=221) were recruited from six African American churches in Atlanta
and surveyed on various influences on clinical trial participation.
Results: Logistic regression models demonstrated that greater transportation mobility (odds
ratio [OR]=2.10; p=0.007) and social ability (OR=1.77; p=0.02) were associated with increased
intentions of joining a clinical trial, as was greater basic daily living ability (OR=3.25; p=0.03),
though only among single participants. Among adults age ≥65 years, those with lower levels
of support during personal crises were more likely to join clinical trials (OR=0.57; p=0.04).
Conclusion: To facilitate clinical trial entry, recruitment efforts need to consider the physical
limitations of their potential participants, particularly basic physical abilities and disabilities.
Crisis support measures may be acting as a proxy for personal health issues among those aged
>65 years, who would then be more likely to seek clinical trials for the personal health benefits.
Outreach to assisted living homes, hospitals, and other communities is a promising avenue for
improved clinical trial recruitment of older African Americans.
Keywords: clinical trials, aging, minority populations, African Americans, physical disabilities
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highlighted potential participants’ psychosocial challenges,
such as distrust of researchers, unexpected costs, and lack of
familiarity with clinical studies.12–14 More recently, however,
attention has been given to factors facilitating access to care
and the health and well-being of older adults such as mobility, social participation, and neighborhood characteristics
such as availability of trials in the residential area.15,16 These
factors have demonstrated an influence on health decision
making among older Black/African American individuals
(e.g., vaccination).17,18
A call to action has been issued for novel strategies to
improve clinical trials participation rates among older African
Americans, who experience greater morbidity and mortality
for many infectious and chronic diseases (e.g., HIV, colorectal cancer, diabetes, hypertension), which could be reduced
through new medical advances.1,19–24 Accounting for physical
disability and functional impairments typical of older persons
is therefore critical to the assessment of a broader scope of
socioenvironmental factors that may be important determinants in realizing greater diversity in future clinical trials.25
This study examines other factors that may influence
enrollment decision making among this highly vulnerable
group, including personal, social, and community barriers
and facilitators. This study assesses considerations associated with clinical research participation drawing upon the
socioecological framework for human behavior.26 Thus, we
examined the interaction between individual-level factors
(sociodemographics, physical abilities such as strength and
mobility, social abilities, errand transportation availability,
and other independent assessments of functional abilities),
interpersonal-level factors (social support and crisis support),
and community-level factors (transportation access).

Methods
Study procedures

Study design and sample
The data were collected from a cohort of 221 African Americans recruited in metropolitan Atlanta, Georgia through a
cluster randomized controlled trial design.26 In conjunction
with this analyses, we also evaluated the feasibility and
potential effectiveness of the “Dose of Hope” intervention
to test whether delivery of a three-session group intervention
increased the proportion of older African Americans who
enrolled in an array of chronic and infectious disease-related
clinical trials.27 Our inclusion criteria included those who
self-reported being primarily Black/African American, ≥50
years of age, a congregant of one of the six African American participating churches, and having no previous history
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of clinical research participation. All participants provided
written informed consent.

Data collection
We conducted surveys with all enrolled participants at baseline and 3-month time points between January 2013 and May
2014. The surveys measured various influences on clinical
trial participation, designed using established macro- and
micro-theoretical models, including the socioecological
model and an extended theory of reasoned action.28–33 As
such, the measures include those pertaining to nested influences from the community- to individual-level, as well as
moderating and mediating influences on attitudes and social
norms toward trial participation.24–26 Items analyzed from this
study included linked data from the baseline and 3-month
questionnaires containing sociodemographic questions (i.e.,
age, gender, education level, income, and relationship status)
as well as functional disability and social support scales.34,35
The primary outcome was the self-reported intention
that individuals would participate in clinical research. It was
measured through a single item on the baseline survey, “On
a scale from 0 (definitely not) to 10 (definitely so), rank your
likelihood of joining a medical research study within the next
6 months.” For this analysis, we dichotomized responses
using a median split, with responses of 6 or below categorized
as less likely to join a study and those 7 or higher categorized
as likely to join a clinical study.

Ethical considerations
The project was reviewed and approved by the Institutional
Review Board of Emory University (IRB 00057210).

Physical and social ability measures
Participant’s physical abilities (“Functional Ability”) and
available social support (“Social Support”) were measured
using multi-item survey instruments. Functional Ability was
assessed through 15 items measuring ability in daily living
and 4 questions measuring long-term physical abilities,
developed from the “Functional Status Questionnaire.”34
Social Support consisted of a 19-item validated instrument
on medical outcomes and social support.35
Social Support and Functional Ability scales were transformed into factor scores for analysis. An expected maximum
imputation was used to impute missing items using other
components of the same scale when >50% of the scale items
were completed. For each instrument, principal component
extraction was performed followed by varimax rotation.
Significant factor loadings were identified as loadings over
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0.5, and crossloading items were removed. Only two items
were removed, both from the Social Support scale: “How
often do you have someone to take you to the doctor if you
needed it?” and “How often do you have someone to confide
in or talk to about yourself or your problems?” The number
of factors was selected for both an eigenvalue over 1.0 and
interpretability.
Factor internal reliability was assessed with Cronbach’s
alpha, with an alpha >0.70 considered acceptably reliable.
All resulting factors from the Functional Ability and Social
Support scales had alpha >0.75. The four items measuring
long-term physical abilities were analyzed via factor analysis
but had poor internal consistency, with alpha <0.70. Finally,
standardized factor scores were computed using the regression method.
The Functional Ability scale scores resulted in four subscales: “Basic Ability”, “Strength and Mobility”, “Social
Ability”, and “Errand Transportation”. Basic Ability
measures the participant’s independence in basic daily life
activities, such as dressing, feeding, or bathing themselves.
Strength and Mobility measures instrumental daily life
activities requiring more functional ability, such as chores,
walking outside the home, and using public transportation.
Social Ability measures functional ability necessary to support social activities, such as the ability to participate in
community activities or visit others. Errand Transportation
measures independence in transportation, like the ability to
drive and do errands such as shopping.
The larger Social Support scale resulted in two subscales:
“Social Support” and “Crisis Support”. Social Support measures the availability of social support in day-to-day life, such
as the availability of others who give advice, show love and
affection, or who are available for recreation. Crisis Support
measures available support from others in the case of crisis
or loss of functional ability, such as help when confined to a
bed or availability of someone to talk to about a crisis.

Analysis
All analyses were completed using Statistical Package for the
Social Sciences (SPSS) version 22 (SPSS, Inc., Chicago, IL,
USA). Descriptive statistics were obtained for all variables of
interest. Bivariate odds ratios (ORs) and prevalence ratios (PRs)
were estimated to explore direct associations between participant
intention to join clinical research and sociodemographic factors,
Functional Ability measures, and Social Support measures.
Bivariate ORs and 95% confidence intervals were estimated
using bivariate logistic regression, and bivariate PRs and confidence intervals estimated by bivariate log binomial regression.
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A logistic regression model was fit to assess the individual and
cumulative associations with the dichotomized outcome. A
Poisson regression using robust covariance estimates was also
fit to estimate adjusted PRs. The robust Poisson model was
chosen over the log-binomial model to facilitate convergence
of estimates.
Of the 221 persons enrolled in the study, 7 participants
did not complete the outcome item at baseline (3% missing),
3 were missing age information (1.4% missing), and 23 were
missing factor scores for either the Functional Ability or
Social Support scales (10.4%); the resulting analysis included
191 complete cases (13.6% overall). The multivariable models included two-way interactions between factor scores and
demographic variables (age, gender, income, education, and
relationship status). Collinearity between independent factors within each model was assessed using variance inflation
factors (VIFs).

Results
Participant and sample characteristics
At baseline, 221 participants completed the survey, while
211 completed the 3-month survey. The mean age was 63.6
years (standard deviation [SD]=7.50), though ages ranged
from 50 to 90 (Table 1). There were 173 females (78.3%)
and 48 males (21.7%). The majority of participants had an
associate’s degree or higher (n=142, 64.3%). There was a
moderate spread of household income, with the plurality
claiming an income below $20,000 (n=61, 27.6%) and fewest
claiming a household income over $100,001 (n=13, 5.9%).
Participant employment varied, with the fewest claiming
part-time employment (n=18, 8.1%) and the most responding that they were retired (n=85, 38.5%). Participants were
primarily married (n=102, 46.2%) or separated/divorced
(n=59, 26.7%). Table 1 also displays the sociodemographic
characteristics of the 191 participants for whom we could
include in the multivariable logistic regression model as they
had complete case data (labeled “complete cases”).
The outcome variable, likelihood of joining a clinical
study at baseline, had a mean score of 5.83 (n=214, SD=2.68)
and a median score of 6 (0=definitely not, 10=definitely so).
The most frequently selected score was a 5 with 42 responses
and 19.0% of all responses.

Functional Ability and Social
Support scales
The 15 Functional Impairment items resulted in four f actors:
Basic Ability (5 items, α=0.97), Strength and Mobility
(5 items, α=0.97), Social Ability (3 items, α=0.97), and
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Table 1 Sociodemographic characteristics of study participants
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Item
Age, years (missing, n=3)
50–54
55–59
60–64
65–69
70–79
≥80
Gender
Female
Male
Race
African American/Black
Multiracial/multicultural
Ethnicity (missing, n=45)
Non-Hispanic
Hispanic/Latino/Chicano
Highest level of education
Kindergarten–8th grade
9th–11th grade
High school graduate/GED
Technical/vocational/associates
Bachelor’s degree
Master’s degree
Doctorate
Household income (missing, n=23)
<$20,000
$20,001–$40,000
$40,001–$60,000
$60,001–$80,000
$80,001–$100,000
>$100,001
Employment (missing, n=8)
Employed – full time
Employed – part time
Unemployed
Other (retired, n=85, 44.4%)
Relationship status
Single/never married
Married/domestic partner
Divorced/separated
Widowed
Other

Total sample (n=221), n (%)

Complete casesa (n=191), n (%)

23 (10.4)
39 (17.6)
58 (26.2)
50 (22.6)
41 (18.6)
7 (3.2)

22 (110.5)
35 (18.3)
50 (26.2)
46 (24.1)
33 (17.3)
5 (2.6)

173 (78.3)
48 (210.7)

146 (76.4)
45 (23.6)

217 (98.2)
4 (10.8)

187 (97.9)
4 (2.1)

175 (79.2)
1 (0.5)

157 (82.5)
1 (0.5)

3 (10.4)
10 (4.5)
66 (29.9)
66 (29.9)
37 (16.7)
33 (14.9)
6 (2.7)

2 (10.0)
6 (3.1)
60 (310.4)
55 (28.8)
33 (17.3)
29 (15.2)
6 (3.1)

61 (27.6)
49 (22.2)
36 (16.3)
20 (9.0)
19 (8.6)
13 (5.9)

50 (26.2)
42 (22.0)
34 (17.8)
18 (9.4)
17 (8.9)
13 (6.8)

43 (19.5)
18 (8.1)
37 (16.7)
115 (52.0)

38 (19.9)
18 (9.4)
32 (16.8)
97 (50.8)

24 (10.9)
102 (46.2)
59 (26.7)
35 (15.8)
1 (0.5)

20 (10.5)
89 (46.6)
51 (26.7)
30 (15.7)
1 (0.5)

Note: aComplete cases are those participants who have responses for all variables included in the logistic regression model.
Abbreviations: GED, General Education Development high school equivalency diploma.

Errand Transportation (2 items, α=0.97). The two resulting
factors for Social Support were Crisis Support (3 items,
α=0.85) and Social Support (14 items, α=0.97). The four
long-term ability items resulted in a single factor with
α=0.698; because the α was not >0.70, these items were
treated individually for analysis.
Items included in the Functional Ability factor scales
demonstrated high levels of ability (Table 2). Within Basic
Ability, average scores ranged from 3.91 to 3.97 (1=no
difficulty, 4=too difficult to do). In the factor of Strength and
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Mobility, the 5 items ranged from 3.11 to 3.76, representing
high levels of strength or low mobility impairment. Within the
category of Social Ability, scores ranged from 3.72 to 3.84,
indicating higher levels of social abilities. Errand Transportation scores averaged 3.92 (SD=0.31) for “…driving a car”
and 3.84 (SD=0.39) for “…doing errands”, demonstrating
high ability to complete errands.
The Social Support factors had mean scores ranging
from 3.87 to 4.30 (1=none of the time, 5=all of the time),
indicating high average availability of social support

Open Access Journal of Clinical Trials 2017:9
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Table 2 Functional ability scale: resultant factors and factor loadings
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Factor “In the past month, have you had difficulty with…”
Basic Ability (a=0.879, 5 items)
Feeding yourself?
Dressing yourself?
Moving in and out of bed?
Bathing yourself?
Walking around your home?
Strength and Mobility (a=0.861, 5 items)
Walking several blocks?
Doing house chores such as cleaning?
Using public transportation?
Lifting heavy objects?
Doing physical activity such as running?
Social Ability (a=0.803, 3 items)
Visiting other peoples’ homes?
Participating in community activities, such as religious services, social activities,
or volunteer work?
Taking care of other people such as family members?
Errand Transportation (a=0.752, 2 items)
Doing errands, such as grocery shopping?
Driving a car?

Meana

SD

Min

Max

Factor loading

3.97
3.95
3.91
3.95
3.91

0.21
0.25
0.31
0.23
0.29

2
2
2
2
2

4
4
4
4
4

0.78
0.90
0.76
0.90
0.59

3.58
3.76
3.72
3.18
3.11

0.75
0.53
0.69
0.92
10.05

1
1
1
1
1

4
4
4
4
4

0.80
0.62
0.61
0.82
0.85

3.80
3.84

0.50
0.44

1
1

4
4

0.80
0.82

3.72

0.64

1

4

0.53

3.84
3.92

0.39
0.31

2
2

4
4

0.63
0.88

Notes: a1= Too difficult to do; 4= no difficulty; to aid interpretation, this scale has been reverse-coded from the original survey instrument.
Abbreviations: Max, maximum; Min, minimum; SD, standard deviation.

(Table 3). Similarly, items included in the Crisis Support
factor had means of 3.67–4.03, also indicating moderately
high levels of crisis support.

Associations with likelihood of joining
clinical trials
Bivariate analysis

Bivariate ORs and PRs were estimated to explore direct
associations between participant intentions to join clinical
trials and sociodemographic factors, Social Support, and
Functional Ability (Table 4). Those participants with greater
access to Errand Transportation indicated greater intention
to participate in clinical research (OR=1.77, 95% CI: [1.09,
2.86], p=0.02; PR=1.24 [1.00, 1.54], p=0.05). No other statistically significant bivariate associations were found amongst
the Functional Ability measures, Social Support measures,
or tested sociodemographic factors.

Multivariable models
Multivariable logistic and robust Poisson models were run to
assess the relationships between sociodemographics, physical
ability, social support, and the outcome variable. The final
model was selected according to potential influences on
clinical trial participation identified by previous research and
theory.15,36 We included two interaction terms based on the
hypotheses that the effect of available Crisis Support would
be moderated by age and that Basic Ability would be most

Open Access Journal of Clinical Trials 2017:9

important for single participants. The final model included
four measures of sociodemographics, the two social support
factors, the four functional impairment factors, and the two
interaction terms. The four long-term physical ability items
were not included due to potential redundancy with the Basic
Ability factor score. Multicollinearity was assessed using
VIFs, and all factors were below five so within acceptable
range.
The final logistic regression model was significant
2
(Χ =22.24, p=0.03) with a Nagelkerke R2 score of 0.15.
The Hosmer and Lemeshow fit test was nonsignificant
(Χ2=5.97, p=0.6), indicating a lack of evidence for poor
fit. The statistically significant factors were very similar
between the multivariable logistic and robust Poisson models. Two independent variables were significantly related to
likelihood to join a clinical study: greater intentions to join
clinical trials were associated with greater Social Ability
(OR=1.77, 95% CI: [1.09, 2.87], p=0.02; PR=1.42 [1.09,
1.86], p=0.009) and greater access to Errand Transportation (OR=2.09 [1.22, 3.57], p=0.007; PR=1.57 [1.14, 2.19],
p=0.008) (Table 5).
Two more variables were significantly associated with
the likelihood to join clinical trials for certain values of a
moderating factor. Greater intention to join clinical trials
was associated with greater Basic Ability, but only among
single participants (OR=3.25 [1.16, 9.10], p=0.03; PR=2.08
[1.24, 3.48], p=0.005). Crisis Support was not significantly
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Table 3 Resultant factors and factor loadings for Social Support scale
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Factor (“How often do you have…”)
Social Support (a=0.974, 14 items)
Someone who shows you love and affection
Someone to have a good time with
Someone to give you information to help you understand a situation
Someone who hugs you
Someone to get together with for relaxation
Someone to prepare you meals if you were unable to do it yourself
Someone whose advice you really want
Someone to do things with to help you get your mind off things
Someone to help with daily chores if you were sick
Someone to share your most private worries and fears with
Someone to turn to for suggestions about how to deal with a personal problem
Someone to do something enjoyable with
Someone who understands your problems
Someone to love and make you feel wanted
Crisis Support (a=0.847, 3 items)
Someone to help you if you were confined to a bed
Someone you can count on to listen to you when you need to talk
Someone to give you good advice about a crisis
Items Removed From Analysis
Someone to take you to the doctor if you needed it
Someone to confide in or talk to about yourself or your problems

SD

Min

Max

Factor loading

4.30
4.15
4.12
4.18
4.04
3.96
4.06
4.00
3.87
4.06
4.07
4.08
4.02
4.18

0.87
0.94
0.95
10.03
10.03
10.17
0.96
0.99
10.17
10.04
10.00
10.01
10.00
10.02

2
1
1
1
1
1
1
1
1
1
1
1
1
1

5
5
5
5
5
5
5
5
5
5
5
5
5
5

0.72
0.81
0.73
0.80
0.88
0.70
0.81
0.85
0.74
0.81
0.79
0.87
0.76
0.79

3.67
4.03
4.01

10.37
10.08
10.07

1
1
1

5
5
5

0.78
0.81
0.86

4.11
4.22

10.10
0.94

1
1

5
5

–
–

Notes: a1=“None of the time”; 5=“all of the time”.
Abbreviations: Max, maximum; Min, minimum; SD, standard deviation.

Table 4 Bivariate associations with likelihood of joining clinical studies
Factor

Odds ratio (95% CI)

p-value

Prevalence ratio (95% CI)

p-value

Age (ref = <65 years)
Gender (ref = m)
Education (ref = Kindergarten–12)
Relationship Status (ref = single)
Social Support
Crisis Support
Basic Ability
Strength and Mobility
Social Ability
Errand Transportation

1.18 (0.68, 2.05)
1.11 (0.58, 2.14)
1.07 (0.60, 1.90)
1.10 (0.64, 1.90)
0.98 (0.75, 1.29)
0.94 (0.72, 1.24)
1.29 (0.82, 2.02)
1.05 (0.79, 1.41)
1.27 (0.88, 1.84)
1.53 (1.02, 2.28)

0.6
0.7
0.8
0.7
0.9
0.7
0.3
0.7
0.2
0.04*

1.10 (0.80, 1.52)
1.06 (0.72, 1.58)
1.04 (0.74, 1.46)
1.06 (0.77, 1.45)
0.99 (0.83, 1.17)
0.97 (0.83, 1.13)
1.12 (089, 1.42)
1.03 (0.87, 1.23)
1.12 (0.92, 1.36)
1.24 (1.00, 1.54)

0.6
0.8
0.8
0.7
0.9
0.7
0.3
0.7
0.3
0.05

Note: *p<0.05.
Abbreviations: CI, confidence interval; m, male; ref, reference.

a ssociated with enrollment intention among participants
under age 65 years (OR=1.21 [0.76, 1.93], p=0.4; PR=1.13
[0.86, 1.48], p=0.4). However, for those over 65 years,
participants with greater Crisis Support were less likely to
express intentions to join clinical trials (OR=0.57 [0.34,
0.98], p=0.04; PR=0.81 [0.68, 0.96], p=0.02). The interaction between Crisis Support and age was significant in both
models (OR=0.47 [0.23, 0.95], p=0.04; PR=0.71 [0.52,
0.99], p=0.04); however, the interaction between relationship
status and Basic Ability was only statistically significant in
the robust Poisson model (OR=0.25 [0.06, 1.09], p=0.07;
PR=0.44 [0.23, 0.86], p=0.02).
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Discussion
Recent reviews of the impact of the NIH Revitalization Act on
clinical trial participation reflect an ongoing need for greater
numbers of African Americans in clinical studies.22 This study
offered confirmation that socioecological factors, extending
beyond psychosocial considerations, were predictive of enrollment in clinical trials among an older population of African
Americans. Social support, high functioning, and mobility
facilitate greater participation in clinical trials in geographic
areas with trial availability. These findings are consistent with
others that have identified environmental factors and social
support as important for achievement of optimal health and
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Table 5 Results of multivariable logistic and robust Poisson regression models for factors associated with likelihood of joining clinical
studies (n=221, missing=30)
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Factor
Agea (ref = <65 years)
Gender (ref = m)
Education (ref = Kindergarten–12)
Relationship Statusb (ref = single)
Social Support
Crisis Support (age <65 years)
Crisis Support (age ≥65 years)
Basic Ability (for single participants)
Basic Ability (for participants with a partner)
Strength and Mobility
Social Ability
Errand Transportation
Interaction of Age and Crisis Support
Interaction of Relationship Status and Basic Ability

Logistic model

Robust Poisson model

Odds ratio (95% CI)

p-value

Prevalence ratio (95% CI)

p-value

1.60 (0.84, 3.05)
1.22 (0.55, 2.68)
0.95 (0.49, 1.85)
1.49 (0.72, 3.06)
0.83 (0.58, 1.17)
1.21 (0.76, 1.93)
0.57 (0.34, 0.98)
3.25 (1.16, 9.10)
0.80 (0.32, 2.05)
1.11 (0.79, 1.58)
1.77 (1.09, 2.87)
2.10 (1.22, 3.60)
0.47 (0.23, 0.95)
0.25 (0.06, 1.09)

0.2
0.6
0.9
0.3
0.3
0.4
0.04*
0.03*
0.6
0.5
0.02*
0.007*
0.04*
0.07

1.24 (0.88, 1.74)
1.11 (0.71, 1.72)
0.98 (0.68, 1.39)
1.25 (0.88, 1.78)
0.91 (0.77, 1.08)
1.13 (0.86, 1.48)
0.81 (0.68, 0.96)
2.08 (1.24, 3.48)
0.92 (0.67, 1.27)
1.09 (0.87, 1.36)
1.42 (1.09, 1.86)
1.57 (1.13, 2.19)
0.71 (0.52, 0.99)
0.44 (0.23, 0.86)

0.2
0.6
0.9
0.2
0.3
0.4
0.02*
0.005*
0.6
0.5
0.009*
0.008*
0.04*
0.02*

Notes: aEffect of age when Crisis Support is 0 (the mean factor score), beffect of Relationship Status when Basic Ability is 0 (the mean factor score), *p<0.05.
Abbreviations: CI, confidence interval; m, male; ref, reference.

well-being among diverse older populations.15,16,37–39 Our
findings offer validation of the broader scope of issues that
may be impacting older African Americans’ willingness to
participate in clinical trials.
We found that the examined sociodemographic factors
were not significantly related to likelihood of joining a clinical study when functional impairment and social support were
taken into account. Gender, age, education, and relationship
status were not found to be significantly related to future
enrollment intentions. Previous studies have demonstrated
disparities among these factors in trial enrollment and in willingness to participate in trials among ill individuals.6,8,36,40,41
That these factors did not seem to affect willingness to participate in clinical trials among our cross-sectional sample
of older church-going African Americans is an encouraging
signal for inclusion of diverse older participants in future
clinical trials. This homogeneity suggests that disparities
in enrollment and willingness to participate in trials among
patients do not necessarily reflect disparities in willingness of
the population. Instead, they may arise from specific barriers
to willingness of specific sick individuals, or from structural
issues in trial enrollment that either increase disparity in
enrollment or differentially affect willingness to participate.
The findings suggest that ability to get to a clinical trial site
(personally or through assisted transportation) was due to
physical challenges, including mobility limitations, an issue
well described in the literature.42
Most of the predictors of enrollment were related to
functional impairment. Lower physical functional level,
and dependency on others to facilitate access to clinics, may
have greater impact on clinical trial enrollment than other
Open Access Journal of Clinical Trials 2017:9

c ommonly perceived factors such as historical distrust of
medical research and lack of knowledge about the medical
field.12–14,43 In turn, the lack of evidence for an association
between social support and willingness to participate in
research suggests that barriers may play a larger role in
clinical trial enrollment than facilitators, a premise not yet
thoroughly investigated in the literature. Even if individuals
have adequate support for their enrollment decision (such
as transportation and emotional support), the inability to get
dressed in the morning is, understandably, a greater hurdle
to overcome.
The associations with three of the four functional impairment factors indicate a high association between overall physical function and the willingness to participate in clinical trials.
Within the entire sample, the higher ability scores as measured
by Basic Ability, Social Ability, and Errand Transportation
significantly predicted higher likelihood of joining a clinical
study. Lack of availability of transportation to research sites
has been previously identified as a barrier to trial participation in both qualitative and quantitative studies as well as our
own.44 The degree to which logistical issues such as transportation access are barriers will likely be highly dependent
upon local circumstances and environmental factors; within
the urban setting of our study, they appear to be a concern.
It is understandable that the barriers associated with
ability to perform daily tasks would also contribute to the
decreased likelihood of joining any study. The types of
physical abilities for these factors include components such
as basic hygiene like bathing and dressing, getting out into
the community, and driving and performing errands. These
are skills that are needed to independently interact with and
submit your manuscript | www.dovepress.com
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participate in the community15,38,39 as well as participate in a
clinical trial. Prior research focuses on enrollment exclusions
related to functional impairment, rather than the logistical
aspects of participation.41 Our findings suggest that even
when trials are designed to allow participation by older individuals with functional impairment, those individuals may
be less likely to seek out trials when not directly referred.
Researchers must be willing to logistically facilitate participation in order encourage participation.
Notably, among those >65 years of age, a lack of crisis
support was a critically important factor that was predictive
of intention to participate in trials. Studies with geriatric
populations have identified crisis support teams as important aid for health care decision making, as they account for
listening to concerns and offering input on dilemmas.45,46
Thus, having the ability to harness similar decisional support resources is an important consideration for those who
may be facing much uncertainty, disability, or comorbidities
in later life. Additionally, physicians perceive lack of home
support networks for managing potential treatment side
effects as a potential barrier to research participation among
older patients, and as a potential barrier to actually attending
appointments at which they may be referred or enrolled.41
However, older individuals lacking crisis support may have
unique needs due to health issues they are facing, for which
the crisis support measure may operate as a proxy. The support they envision receiving from providers and support staff
conducting clinical trials, and their broader social network
supporting their enrollment decisions, may therefore be an
attractive perceived benefit that they associate with participation in clinical studies.27,30,47,48
Our findings offer important guidance to investigators
and their clinical research staff on successful recruitment
strategies for older African Americans. Qualitative inquiry
may augment these findings to offer important insight on
social and functional issues encountered by this population
and how to address these challenges. Foremost among the
suggestions is to work with nursing or personal care aides
to reach those who need added assistance with their living
functions. This may be within residential communities or
facilities that serve this population. In addition, the items
related to a support system that includes both someone who
listens and someone who gives advice hearkens to the strategy
of partnering with trusted sources of care and community
members who may have a broad reach among seniors. Thus,
enlisting pastors and faith leaders in trial participation and
recruitment might help address the barriers to participation
among older seniors who are dependent on others for daily
and crisis support.26,30
28
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Limitations
We recognize the limitations of our study design that employed
serial cross-sectional behavioral measures of which causality
may not be directly determined. We also recognize the limitations of self-reported data, as participant, recall, and social
desirability bias may have been a factor; however, previous
research with elderly persons has shown that intention, while
mediated by attitudes, is correlated to actual behavioral outcomes in both health behavior and volunteerism.49,50 Because
our sample is drawn from older African Americans attending
African American churches, our results may not generalize to
older African Americans who are not church members. However, we feel that our study encompasses a significant portion
of this population; a 2009 survey reported that 53% of African
Americans of all ages attend church on a weekly basis; further,
64%–65% of African Americans ages ≥50 years are affiliated
with a historically Black/African American Christian church.51

Conclusion
This study found that previously unexplored factors such as
physical/environmental and social issues may have on clinical
trial recruitment potential among older African Americans.
Our findings illuminate important implications for consideration of logistical issues, such as the role of transportation
options and social support. In addition, the findings offer
direction for the pursuit of other nontraditional venues to
increase participation of those who are homebound or who are
functionally impaired. Alternative recruitment venues such as
nursing homes may be necessary to adequately incorporate
participants who cannot be recruited in traditional settings.
In addition, studies may need to be best adapted to operate
in institutions where seniors reside, such as senior living
facilities or nursing homes, to ensure full participation with
fewer impediments.
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